One-third fewer C2 cells were found to be in S-phase when compared to neighboring ganglia, and apoptotic cells were more than three times more abundant in C2 than in conventional DRG at this stage. Since growth factors modulate both proliferation and apoptosis, we postulated that these molecules and/or their receptors might be responsible for the difference in fate between C2 and C5. In order to begin to evaluate this hypothesis, we have now treated embryos with nerve growth factor (NGF ) in ovo. NGF treatments partially rescued C2, producing a 50% reduction in the normal difference in size between C2 and C5 at St. 23. At least part of this rescue could be accounted for by increased levels of proliferation in the NGF-treated C2 compared to those in control embryos. Proliferation in normal DRG C5 was unaffected by NGF application. NGF treatment rescued DRG cells in both C2 and C5 from cell death. Staining of pycnotic nuclei revealed that NGF dramatically reduced the death in the C2 ganglia. In addition to providing insight into the early patterning of the DRG, our results shed new light on the best-studied neurotrophic factor, NGF. Our finding is the first direct evidence for a role for NGF in control of DRG cell proliferation in vivo. ᭧
INTRODUCTION
amniotic species (reviewed in Lim et al., 1987) . In humans and mice, the first permanent DRG is in cervical segment 2 (C2). In chicken embryos, C2 degenerates leaving C3 as The meristic series of dorsal root ganglia (DRG) arise the most rostral ''permanent'' DRG. from the migration of neural crest (NC) cells into the rosMuch more recently, two studies were made of the ontogtral half sclerotomes. A striking example of axial pateny of the Frorieps ganglia, DRG C2, in chick embryos. In terning among the DRG is that the ganglia that develop the first study by Lim et al. (1987) , it was confirmed that in the most rostral several somites (occipital and first cerneural crest cells indeed migrated into the rostral halves of vical) disappear early in embryogenesis. The initial desclerotomes 2 -6 and formed DRG that eventually degenerscription of these transient DRG in the first sclerotomes ated. The authors also found that neurons developed in was attributed to Froriep by His nearly 100 years ago, and some of these ganglia. Finally, from transplant experiments this observation was subsequently made in a number of that they performed they concluded that the reason Froriep's DRG do not survive is because ''cranial halves of the occipital sclerotomes lack factors essential for DRG sur-Soon after this paper appeared, a study was made of the Charite et al., 1994; Alkema et al., 1995) . Over the past 8 years or so, homologues of the Drosophila HOM complex ontogeny of the nervous system of the junction between genes have been found in animals from C. elegans to man. the head and the trunk (Kuratani et al., 1988) in the chick
The conclusion drawn from studies on pattern formation embryo. C2, the longest surviving Froriep's DRG, was first in the vertebral column and the hindbrain has been the observed by neurofilament staining at St. 20 (E3) . At St. 23 formulation of a hypothesis that the expression of select and 24 the C2 ganglion had a distinct peripheral root and sets of Hox genes, a ''Hox code,'' is responsible for the deterwas located dorsally. The C2 ganglion was found to be dismination of positional identity in vertebrates (McGinnis tinctly present until at least St. 27. The ganglion was found and Krumlauf, 1992) , in analogy to their determining segin whole mount to have an unusual form, being relatively mental identity in the fly. The fate of Froriep's ganglia has spherical and dorsally located at later stages.
shown to be modifiable by changing Hox gene expression. The findings of the above studies have recently been conFor example, the mouse Froriep's ganglion C1 (first cervical firmed and considerably extended (Rosen et al., 1996) . HNKganglion) was temporarily ''rescued'' by overexpression of 1 antibody staining of whole embryos from St. 10 to 21, the developmental patterning gene Hoxb-8 (Charite et al., which delineates not only developing axons and nerve cells 1994) in transgenic mice. This was interpreted to be a ''poslike neurofilament antibodies, but also virtually all of the terior transformation'' making the C2 ganglion more simineural crest (NC) precursors that migrate to form the anlage lar to DRG in more caudal segments. of the DRG (Bronner-Fraser, 1986) , generated the following As a result of several years of intense study, an entire ''life history'' of the ganglion that develops in C2. Neural family of neurotrophic factors related to NGF have been crest cells migrate from the neural tube at the level of the isolated, the neurotrophins. Members of this family, includsixth somite at about the 13 somite stage, St. 11. By St. 14, ing NGF, BDNF, and NT-3, have been shown to have multithe NC cells are colonizing its rostral portion to form the ple effects on chick DRG neurons and their precursors inanlage of a DRG. Within a few hours at St. 18, a convencluding enhancement of differentiation and proliferation, tional looking DRG forms in C2 that is indistinguishable but all have in common the ability to support the survival from the permanent DRG in the adjacent more caudal segof some neurons that would otherwise undergo apoptosis ments. The C2 ganglion begins to appear different from its (reviewed in Davies, 1994) . Other unrelated factors such as neighbors at St. 19 -20, when the ganglion takes up a rela-GDNF (Tomac et al., 1995) and SCF (c-kit ligand) (Carnahan tively dorsal position in the sclerotome, and its peripheral et al., 1994) also have trophic effects on DRG cells. Different root is distinctly thinner than that of C3. By St. 23, the root populations of these cells are apparently dependent on difis much reduced in comparison to that of C3 and more ferent factors (i.e., Carrol et al., 1992) . It is believed that caudal DRG and is often missing altogether. some of these factors are provided to early DRG cells by Computerized quantification of serial camera lucida tracthe neural tube (Kalcheim and LeDouarin, 1986) , but interings of the C2 (Frorieps) and C5, C6 (conventional trunk) action with the mesodermal microenvironment may be ganglia revealed that at St. 18, all these DRG have the same necessary for their normal function (Brill et al., 1992) . At volume. However, as development progresses, the trunk later stages, survival factors are provided to sensory neurons and C2 DRG continue to grow, but at different rates. At St.
endings in the periphery, and their continued supply is nec-19-20, two conventional DRG C5 and C6 were twice the essary for neuronal survival or, in other words, prevention size of C2, but not different from one another. This differof apoptosis (reviewed in Oppenheim, 1991) . ence in size grows until St. 32, when C5 is almost three Some fundamental difference first arises between C2 and times the size of C2. By St. 36, C2 had completely degenerother DRG at St. 18-20 (Rosen et al., 1996) . Since both cell ated in 80% of embryos examined. division and death in the nervous system are modulated Two important morphogenetic processes, proliferation by neurotrophic factors, it is possible that C2's demise is and apoptosis, were found to participate in producing the brought about patterning of trophic factor/receptor expresearly differential in growth between C2 and normal DRG.
sion. In order to test this hypothesis, embryos were treated in ovo with a well-known growth factor to see whether it First, using a double-label immunocytochemical procedure could change the fate of the C2 ganglia. We present evidence (Avivi et al., 1994) more than 30% more cells were observed that NGF application in ovo specifically modifies the develto be in S-phase in normal DRG C5 than in C2 at St. 19 -opment of the C2 ganglion, at stages preceding those when 20. The early DRG were then examined for apoptosis. It is NGF was thought to have an effect on DRG cells. In addiintuitively obvious that at some stage of development, large tion, we show that NGF increases the proliferation of DRG amounts of apoptosis must produce the removal of C2 by cells in C2, the first report to our knowledge of a positive St. 36. However, it was not clear when this process might effect on cell division of neuroectodermal derived cells by begin. There was indeed a significant amount of apoptosis this well-studied factor. at St. 19 -20 in C2, with only rare dead cells in C5 at this stage. In addition, when apoptosis in normal cervical DRG
METHODS
is at its peak at St. 28, even more massive apoptosis is present in the C2 ganglia.
Numbering of DRG
Studies of pattern formation in mice have recently spotAs described above, the DRG that form in the most rostral somites degenerate early in embryogenesis, while the corresponding lighted the Frorieps ganglia (i.e., Kessel and Gruss, 1991; motor nerves remain. In the chick embryo, the first four nerve embryos. The other half of the treated embryos had ratios of C5/ C2 volume averaging 1.7 or less, more than 20% lower than normal. roots coursing through somites make contributions to the hypoglossal nerve, and the fifth is the first cervical (C) spinal nerve (Lim Therefore, only these embryos were included in the quantitative analyses. Qualitative examination of the C2 ganglia in the NGFet al., 1987) . As a result of this degeneration of the rostral DRG therefore, the first permanent DRG is associated with the third treated embryos showed that all C2 DRG that responded to NGF quantitatively were also qualitatively different from C2 in controls. cervical (C) spinal nerve and is termed C3, and the longest-lived (most caudal) Frorieps ganglion is C2.
In normal embryos, C2 has a distinctive profile in cross section and little or no peripheral nerve root ( Fig. 2A) . In all those embryos In order to be sure that the C2 was correctly identified in all embryos (especially those which had received NGF and whose morin which NGF had an effect on C2/C5 volume ratio, the shape of C2 was strikingly changed to be similar to that of C5 (Fig. 2C ) and phology might be modified) it was critical to find a set of criteria for determining the axial identity of DRG at the rostral end of the had substantial nerve roots. Many embryos that were rejected for the quantitative analysis responded to NGF in this qualitative manspinal cord. DRG were identified as C2 if they fulfilled the following criteria. First, they were continuous with the ''ganglion crest, '' ner, displaying a C5-like profile and a nerve root. The variability in the quantitative responses can likely be attributed to the early the remnant of the more rostral Froriep's ganglia (Fig. 1) . Second, they were the last dorsal neural structure that was continuous with stage at which the NGF was administered. At St. 17-18, the network of blood vessels is not yet well developed, and it is likely the ganglion crest and obviously separated from the next most caudal DRG, C3. Finally, the C2 ganglion is located opposite the that in some embryos, the NGF administered simply diffused away from the site of application because of the mechanical handling of junction between the hindbrain and spinal cord. At this rostrocaudal level of the axis, the neural tube was consistently 20% larger in the egg. In addition, it is difficult to accurately stage embryos in situ, and it is possible that degenerative changes may have already cross-sectional area than at cervical levels in all untreated embryos (quantitative data not shown). This can also be seen clearly in both begun in C2 in some of the embryos. For estimation of proliferation, embryos were given a pulse of the 3D reconstructions and photomicrographs in Figs. 1 and 2.
The C5 ganglion was used as an example of a control, normal bromodeoxyuridine (BrDU) before fixation, triple stained with anti-HNK-1 and anti-BrDU antibodies, and counterstained with hema-DRG in all experiments. This is because the development of this specific DRG was examined in detail in a previous study of Froriep's toxylin. A total of 10 each of C2 and C5 DRG from five embryos that responded to NGF were compared to the same number of DRG ganglia (Rosen et al., 1996) and other studies of pattern formation among the early DRG (Goldstein et al., 1995) .
from five carrier-treated controls. This technique is detailed in Avivi et al. (1994) . Three-dimensional reconstructions were made from camera lucida drawings of HNK-1-stained embryos as described previously (Goldstein et al., 1995; Rosen et al., 1996) .
Application of Growth Factors
Eggs were opened under sterile conditions, the shell membrane was reflected, and NGF (2.5S, Chemicon) was delivered as 1-mg
Quantitation of Apoptosis
pulse dissolved in 0.1% albumin in 50 ml of PBS. NGF was applied Estimation of the numbers of dying cells was performed using either to the chorioallantoic membrane or into its cavity of emconventional nuclear staining in paraformaldehyde (PAF )-fixed embryos at St. 17-18, the stage immediately before the qualitative and bryos, a technique that is sensitive enough to demonstrate quantitative differences arise between C2 and other DRG (Rosen et apoptosis in younger, St. 20 embryos (Rosen et al., 1996; Abbadie al., 1996) . Control embryos received application of albumin/ PBS. et al., 1993) . With PAF fixation, chromatin was preserved as a fine The embryos were then returned to the incubator, and a second, meshwork in normal cells, resulting in the easy distinction of identical dose was administered the next day, at approximately St. small, densely (or brightly) stained pyknotic nuclei. These in turn 21. In a few experiments 5 mg per dose was used, but this was were easily distinguished from the larger erythrocytes with their not any more effective in rescuing the C2 DRG (data not shown).
less dense nuclei and from mitotic figures. In the current study Embryos were sacrificed at St. 23 and then fixed in Bouin's fixative either Hoechst and hematoxylin nuclear staining combined with for proliferation studies and 4% paraformaldehyde in PBS for HNK-1 immunostaining (rhodamine) or fast-green, respectively, to apoptosis studies. Embryos were then embedded in paraffin and delineate the ganglia was used (Fig. 4) . As was the case in the serially sectioned.
proliferation studies, 50% of embryos that were treated with NGF responded with increased size of C2. A separate set of 10 each of C2 and C5 DRG from five NGF and five control embryos were
Determination of Volumes, Estimation of
used for the analysis of cell death.
Proliferation, and 3D Reconstructions
TUNEL staining labels dying cells that have begun to enter apoptosis, before they display the typical nuclear morphology of In order to determine the volumes of the C2 and normal ganglia, camera lucida drawings were made of DRG in each of the serial this type of cell death (Gavrieli et al., 1992) . We were unable to produce consistent, homogeneous staining of complete sets of sesections and measured with a digitizer attached to a PC (Goldstein, 1993; Gvirtsman et al., 1992; Goldstein et al., 1990) . The DRG rial sections necessary for quantitative analysis using this technique. However, since we were interested in the ratio of dying cells were delineated by staining with the HNK-1 antibody (Goldstein, 1993) . In normal embryos examined in a previous study, and in the between different DRG and not their absolute numbers, our use of the less sensitive technique of pycnotic nuclear morphology was carrier-treated embryos in this study, the volume of C2 was about half of that of C5 (Rosen et al., 1996) . sufficient. In all figures depicting volume measurements and cell counts, NGF-treated embryos exhibited a bimodal distribution of results with respect to this volume ratio of C2/C5. In exactly half of the the error bars represent the standard error of the mean (SEM). The statistical significance between groups of DRG was determined embryos (10 of 20), C2's volume was similar to that of controls, and the ratio C2/C5 was very similar to the average value for control with Student's t test.
FIG. 1.
3D reconstructions of the nervous system at the junction between the brain and the spinal cord in PBS-(A and B) and NGFtreated (C and D) embryos at St. 23. In control embryos, the C2 ganglion is small and dorsally located (see also Fig. 2 ). After NGF treatment, the ganglion is shaped more like neighboring, conventional ganglion C3, and a root connecting it to the spinal nerve remains. Note that in both normal and control embryos, the neural tube is larger at the C2 level. This is because this is still the medulla; the spinal cord only begins at the level of ganglion C3, the first permanent DRG (this is also evident in the photomicrographs in Fig. 2 ). In addition, C2 in both reconstructions is continuous with the remnant of C1, but separate from C3. The neural tube is depicted in blue, the ventral roots and spinal nerves in green, and the DRG in yellow.
section than normal DRG (Figs. 1A and 1B) . This can also
RESULTS
be seen in the photomicrographs of cross sections through C2 and C5 in Figs. 2A and 2B. As described under Methods,
The C2 Ganglion at St. 23
C2 is continuous with the remnants of the more rostral DRG In order to understand the effects of NGF on C2's developthat have already degenerated and is separate from the first ment, a brief comparison of this ganglion to that of a typical permanent DRG, C3. The differences between C2 and norcervical DRG C5 at St. 23 in normal chick embryos is premal ganglia were also quantitative. At St. 23, the C2 ganglion sented. Three-dimensional reconstruction of the neural tube occupied about one-half the volume of conventional DRG and dorsal neural structures from C1 to C5 revealed that the C5 (Fig. 3 ) (n Å 10 each C2 and C5 DRG from five embryos, shape of C2 was quite different at St. 23. Throughout virtu-P õ .0001). In contrast, C6 was virtually the same size as C5 at this stage (data from Rosen et al., 1996) . ally its entire rostrocaudal extent, C2 was smaller in cross FIG. 4 . Photomicrographs of sections used for proliferation (A) and cell death (B -F ) studies. In A, the nuclei of cells that are in S-phase are stained brown, the nuclei of cells that are not in S-phase are blue (arrows). The open arrow points to a mitosis in the neural tube (NT). The ganglia (DRG) and neural tube are stained pink. Bar, 25 mm. Abbreviation: C, neural canal. In B, a section through DRG C2 in a PBS-treated embryo is shown. Apoptotic nuclei are visible even at this low magnification (arrows). The pycnotic nucleus adjacent to the upper arrow in B is seen at higher magnification in C. An open arrow points to a mitosis in D, which is easily distinguished from the nearby pycnotic nucleus (arrowhead). Bright green cytoplasm and light staining nuclei are characteristic of erythrocytes in these preparations, and an example is shown adjacent to the open arrow in E. Nucleoli are not easily discerned in normal nuclei because the paraformaldehyde fixation leaves the chromatin a fine meshwork. Fast green stains the cytoplasm of most apoptotic cells strongly. F shows several dying motoneurons in the abortive cervical column of Terni (Oppenheim et al., 1982) in the neural tube of an NGF-treated embryo. Bars in A and B, 25 mm; bar in F, 10 mm; C -F are the same magnification.
FIG. 2.
Photomicrographs of cross sections of C2 and C5 where they reach their maximal cross-sectional area in PBS-treated (A, B) and NGF-treated (C, D) embryos. Sections were stained with the HNK-1 antibody to delineated the nervous system. In carrier-treated (and untreated, Rosen et al., 1996) embryos, C2 is dorsally located and rounded in cross section. In most of these control embryos there is no connecting root between C2 and the ventral root. After NGF treatment the ganglion appears more elongated, and a substantial sensory root (SR) is present. For comparison, cross sections through C5 in the same embryos are shown in (C and D). Bar, 85 mm. Abbreviations: SR, sensory root. VR, ventral (motor) root. NT, neural tube.
In Ovo Application of NGF Rescues the Froriep's
23 was more than twice the volume on average of C2, and NGF treatment reduced this par by 50% (Fig. 3) . In other Ganglion words, NGF ''rescued'' about 50% of the C2 DRG in terms It has recently been shown that the qualitative and quanof volume. This increase in size of C2 caused by administratitative differences between C2 and C5 appeared at St. 19 -tion of NGF was significant (n Å 10 each C2 and C5 DRG 20 (see above). Growth factors are molecules known to in each experimental group, P õ 0.001). The C5 DRG in modulate the two cellular processes that differed between NGF-treated embryos were slightly larger on the average C2 and normal DRG, division and apoptosis. Therefore, an than those in the controls, but this difference was not sigattempt was made to reverse this process of degeneration nificant. There was also an increased number of cells in the or ''rescue'' the C2 DRG by direct application of NGF to C2 ganglia as a result of NGF treatment. proliferation, the proportion of DRG cells in S-phase was determined (i.e., McMillan-Carr and Simpson, 1978; Ockel et al., 1996) . A double-immunocytochemical technique of BrDU incorporation coupled with HNK-1 immunocytochemistry for delineating the early ganglia was used (Avivi et al., 1994; Goldstein et al., 1995) . Photomicrographs of a cross section of a St. 23 DRG stained in this manner is shown in Fig. 4A .
In carrier-treated controls, the percentage of cells in Sphase, or proliferation index (PI, McMillan-Carr and Simpson, 1978) , in C5 at St. 23 was 34.7 { 1.4%. This value is in agreement with that obtained in an earlier study of DRG cell PI in normal embryos at St. 23 using [
3 H]-thymidine (Goldstein et al., 1990) . The PI of cells in C2 was 25.9 { 0.9, about 25% less than that in C5 (n Å 10 DRG from five embryos; P õ .001). In NGF-treated embryos by contrast, this measure of proliferation in was almost equal in the C2 and C5 ganglia. 36.125 { 1.0% of cells in C2 incorporated BrDU compared to 37.0 { 0.8% to 25%, i.e., C2 is 75% the size of C2. n Å 10 normal (Rosen et al., 1996) , 14 NGF-treated, and 12 carrier-treated DRG. Error bars represent SEM.
Cellular Processes in C2 Modified by NGF II. Apoptosis
As discussed above, NGF is well known as a survival factor for neurons. Therefore, the possibility that the exogeunchanged at 2557 { 191. The increase in cell number was also significant (P õ .001).
In addition to quantitative effects, the NGF-treated C2 ganglion had an appearance more similar to that of normal DRG C5, with a larger cross-sectional area in each section, and an elongated shape. This can be seen in both the 3D reconstructions of a normal and an NGF-treated embryo in Fig. 1 and the photomicrographs in Fig. 2 . Another striking effect of NGF was on the peripheral root of sensory fibers that connect the DRG to their corresponding ventral roots to form mixed nerves. In normal St. 23 embryos this root had all but degenerated in C2. In contrast, it was present (to varying degrees) in all NGFtreated embryos (Figs. 1 and 2 ).
Cellular Processes in C2 Modified by NGF I. Proliferation
The effect of NGF treatment on two cellular processes that could contribute to differences in growth between C2 and C5, proliferation and apoptosis, were then examined. Although NGF administration is known to have mitogenic be due to an effect on cell division. In order to estimate nous application of NGF also might have an effect on cell death in the C2 DRG was investigated. An additional series of embryos were treated in ovo with NGF using the same protocol as described in the proliferation studies above. Upon sacrifice, these embryos were fixed in paraformaldehyde and stained using the nuclear stains Hoechst or hematoxylin (Fig. 4) . Although St. 23 is considered to be before the onset of natural apoptosis in avian cervical DRG (McMillan-Carr and Simpson, 1978; Hamburger et al., 1981) we and others have previously shown that pycnotic nuclei can be observed in DRG as early as St. 20, when using this means of histological preparation (Rosen et al., 1996; Abbadie et al., 1993) . In that study, there were significantly more dying cells present at St. 20 in the C2 DRG than in normal DRG C5.
In carrier-treated St. 23 embryos, the number of dead cells per ganglion was about twice as great for C2 than C5. If one 75% (7.7 { 1.4) and in C5 50% (3.1 { 1.1) (Fig. 6 ). Both of these reductions were statistically significant (P õ .001). Pycnotic nuclei, although rarer, were as easily distinguished in the NGF-treated as in normal embryos. Dying cells were sive apoptosis in these peripheral ganglia. This is because NGF is generally viewed as a survival factor for differentifrequently observed in the ventral neural tube at the C5 level of the axis in both PBS and NGF treated embryos ated neurons rather than a factor affecting precursors in DRG. The earliest effect of NGF in vivo demonstrated (Fig. 4F ). These cells were likely to be those of the cervical column of Terni that begins to degenerate at about this previously was upon the primary sympathetic ganglia (Oppenheim et al., 1982) . NGF administered on E3 (St. stage (Oppenheim et al., 1982) . 20) increased the size of these ganglia by about 20% when measured at St. 24 -25. In that study, no change was found in pyknotic cells number after NGF treatment, and prolif-DISCUSSION eration was not studied.
Most in vitro studies of the effects of NGF have also In this study, we examined the effect of the best-characterized neurotrophic factor, NGF, on the programmed deconcluded that it does not affect DRG cells until later in development (Davies, 1994) . Sensory neuron precursors in generation of the chick Froriep's ganglion C2. NGF significantly reduced the large morphological and size difference culture are thought to be initially independent of growth factors. They then develop a dependence on BDNF and NTbetween C2 and the conventional cervical ganglion C5. This rescue resulted from both an increase of proliferation and a 3, other members of the neurotrophin family. (The same is true for the well-studied neural crest-derived, NGF-depenreduction of apoptosis in NGF-treated C2, compared to this ganglion in vehicle-treated controls. By contrast, NGF did dent trigeminal ganglion sensory neurons (Wright et al., 1992) ). However, several studies from Bernd's laboratory not have any significant effect on the size or shape of normal DRG [although it reduced the very low levels of cell death suggest that this view may be overly simplistic. First, it was observed that NGF could increase cell number of DRG cells in C5 (see below)].
cultured from St. 23 quail DRG. In that study, it was not determined whether this was a result of increased survival
Early Effect of NGF in Vivo
or proliferation (Speight et al., 1993) . Other studies from her and other's laboratories showed that NGF, as well as To the best of our knowledge, our results are the earliest demonstration of an effect of NGF on DRG cells in ovo.
trkA (Zhang et al., 1994) and p75 LNGFR (Hallbook et al., 1990; Heuer et al., 1990) mRNA are present before the onset of Several previous studies have evaluated the effect of NGF administration on apoptosis in the DRG of the chick emprogrammed cell death in the DRG at St. 24-25. These observations provide a molecular basis for our observations bryo (i.e., Oppenheim et al., 1982; Hamburger et al., 1981) . However, in those studies the embryonic period (see below).
In the neurotrophic theory, apoptosis results from insufexamined was from St. 25 -36, during the period of mas-ficient survival factor retrogradely provided to the soma prevention of cycling precursors from undergoing their terminal mitosis and withdrawing from the cell cycle. by retrograde transport from axon terminals (Oppenheim, 1991) . The cell death that takes place in C2 at St. 20 (Rosen This latter possibility seems unlikely, however, because NGF is known to stimulate differentiation and not to et al., 1996) or St. 23 is not likely to follow this classic pattern. At St. 20, the somitic mesoderm has just begun to prevent it in several experimental systems (Green and Tishler, 1976; Anderson and Axel, 1986) . separate into sclerotome and dermomyotome. Axons are just traversing the sclerotome at this time, a tissue that is DRG at the stages examined in this study contain neurons, glia, and (primarily) their precursors. Preliminary renot a target for either sensory or motor neurons. At the stage examined in the current study, St. 23, axon bundles sults have revealed that at least some of the additional cells that are generated/survive as the result of NGF treatment have reached the dermomyotome at cervical levels of the axis, but very little branching and few nerve endings are are neurons. Daily administration of NGF for an additional 3 days led to a large increase in the size of the C2 ganglion observed in the nascent myotome and dermatome (unpublished observations). In addition, even by St. 23, only a small when embryos were examined at St. 28 (E6). These hypertrophied ganglia contained many more large neurons than C2 portion of the cells in the DRG have passed their final division and differentiated into neurons (McMillan-Carr and DRG from untreated embryos at this stage. Moreover, in carrier-treated and normal embryos at this stage of developSimpson, 1978), a prerequisite in these cells for growing axons (unlike sympathetic neuroblasts that differentiate ment, C2 never had a root of fibers connecting it with the ventral root to form a normal spinal nerve. C2 in these while still mitotic).
NGF-treated embryos had such a root, again suggesting an increase in the number of neurons (in preparation).
NGF and Proliferation
NGF has been shown to stimulate proliferation of several nonneuronal cell types including mast cells, chromaffin Our results are the first to demonstrate an in-vivo enhancement of proliferation of DRG cells by NGF, albeit cells, keratinocytes, and supporting cells in sympathetic ganglia (references in Muller et al., 1994) . Although NGF in an atypical ganglion. Increased proliferation was the original mechanism proposed for NGF's increase of neuis generally thought of as a survival/differentiation factor for neuroepithelium-derived cells, there have been several ron number in chick DRG and sympathetic ganglia by Levi-Montalcini. However, this hypothesis was subsereports suggesting that NGF may be involved in the proliferation of neural precursors. In one study, injections of antiquently shown to be incorrect, apparently the result of inadequate morphometric techniques (for review see Jabodies to NGF or p75 LNGFR into the CSF were shown to reduce the incorporation of thymidine into precursors of cobson, 1991). In normal ganglia NGF did not affect the PI of DRG cells at St. 23. It is important to point out granule cells of the rat cerebellum (Muller et al., 1994) . These antibodies also prolonged the cell cycle of this poputhat the increase of PI observed in C2 only brought cell division to the same level as that in normal DRG. This lation. From these results and complementary in vitro experiments, the authors proposed that NGF is indeed insuggests that locally supplied NGF may be generally involved in control of early DRG cell proliferation, but the volved in the control of proliferation of these neurons. In a study of the embryonic auditory system in vitro, it was factor or its receptors are normally present at saturating levels. Continuous application of large quantities of neuobserved that NGF could increase the size of explanted otic vesicles and cochlear -vestibular ganglia (Represa and tralizing anti-NGF antibodies from E3 to E11 has been shown to reduce the numbers of chick DRG neurons in Bernd, 1989) . Experiments using a somewhat indirect method to distinguish between proliferation and survival ovo when embryos were examined at E11 (Rohrer et al., 1988) . It is possible that part of the antibody's effect was effects led to the conclusion that NGF was likely to be controlling proliferation in this system as well. They to reduce proliferation, as well as cell survival. This could be tested by evaluation of the PI in younger (E3 -4) empointed out that the NGF's effect could have been indirect, acting through responsive support cells that in turn release bryos that had received anti-NGF at early stages.
The increased PI in C2 strongly suggests that NGF's another factor producing neural proliferation. In another in vitro study, the long-term treatment of brain stem cells effect is on proliferation rather than upon survival of cycling DRG precursors. This is because if only survival with NGF increased their proliferation (Cattaneo and McKay, 1990) . However, the NGF concentration was high was enhanced, the absolute number of BrDU-labeled cells would have increased, but not their percentage of the popin these experiments, and the effect of NGF was dependent on the presence of a known mitogen, bFGF, so the relevance ulation (DiCicco-Bloom et al., 1993) . (This argument holds true assuming that the DRG contains a more-orof these experiments to normal development of these cells in the brain is unclear. less homogeneous population of precursors. NGF could potentially selectively support the survival of a subpopuAn in vitro study of St. 23 quail DRG showed that NGF increased by 30% the number of neurons after 24 hr in lation of cycling precursors, producing an increase in the proportion of cells in S-phase.) The increased PI in C2 culture (Speight et al., 1993) . This is in spite of the fact that this stage precedes the innervation of peripheral tissues. In resulting from NGF application could result from shortened cell cycle times (Muller et al., 1994) or from the that study, however, there was no attempt to discern be-tween survival and proliferative effects of NGF. Our prelimbeen shown in several systems that NGF can induce the expression of its receptors p75 and trkA (reviewed in Davies inary observations of increased neural numbers in C2 in long-term treated embryos differ from all the above studies, et al., 1995) . It is possible that such a phenomenon could contribute to the observed rescue of C2 by NGF. This is therefore, in that this is the first case of the upregulation of proliferation by NGF on neural precursors in vivo.
especially possible in light of the fact that in the treatment regimen used, the first dose of NGF could induce receptors that increase the response to the second dose. Another pos-
NGF Receptors
sible complication is that the effect of NGF on the DRG could be indirect, as pointed out by Repressa and Bernd What are the possible mechanisms for our observed rescue of C2 by exogenous NGF? mRNAs for NGF, and its (1989) . p75 receptors are found in a great variety of tissues, and it is possible that one of these tissues could release a high-affinity receptor trkA, are present in DRG from St. 23 (the earliest stage they can be dissected), as detected by RTfactor that in turn modulates DRG proliferation/apoptosis. PCR (Zhang et al., 1994) . The physiological effects of NGF are thought to be primarily mediated by its high-affinity Early Cell Death in the DRG and Its Reduction by receptor, trkA. However, trkA levels are apparently very NGF low at this stage, since they cannot be detected by in situ hybridization, only RT-PCR. The physiological effect meNumerous studies utilizing various techniques have shown that NGF is a survival factor for DRG neurons. In diated by trkA in DRG has been on survival of neurons, so at this stage that precedes innervation and retrograde supply the chick, the programmed cell death period in the DRG was shown to start at St. 25 (McMillan-Carr and Simpson, of NGF, it is not surprising that it is not highly expressed. The low-affinity receptor p75 is detectable from neural crest 1978; Hamburger et al., 1981) . Using a somewhat more sensitive technique, we and others have recently shown that migratory stages in the rat by immunocytochemistry (Yan and Johnson, 1988) and in the chick by in situ hybridization apoptosis can be detected in the nascent DRG as early as St. 20 (see Methods). Very low levels of cell death in normal (Hallbook et al., 1990; Heuer et al., 1990) .
Since p75 is apparently expressed earlier in development DRG C5 were observed at this stage; in C2 by contrast, there were more than four times as many pycnotic nuclei. than trkA, we speculate that p75 is at least partially responsible for the effect observed on proliferation. Evidence from Using the same techniques as used in that study, it was now found that at St. 23 there is slightly more death than several other studies supports the conjecture that this receptor pathway may indeed by involved in proliferation. First, at St. 20 in normal cervical DRG such as C5. At this stage as well, the levels of apoptosis in C2 were again about four as mentioned above, cerebellar granules cells proliferate less when anti-p75 antibodies are administered intrathecally times greater than in C5. NGF treatment in ovo dramatically reduces the levels of cell death in C2. NGF also re- (Muller et al., 1994) . In addition, as mentioned above, the levels of p75 are much higher than trkA at these early emduces the low level of cell death present in C5 at St. 23, in contrast to the lack of its effect on proliferation in this bryonic stages. High levels of p75 are observed in the E3 chick facial nerve (Vazquez et al., 1994) and auditory system conventional DRG. This reduction of cell death at such early stages by NGF (Represa and Bernd, 1989) when neural precursor proliferation is still taking place in these structures.
is somewhat surprising. Death of DRG neurons from lack of NGF is believed to be the result of unsuccessful competiIf this hypothesis is correct, one would expect to find differential expression of NGF and or p75 in normal emtion for trophic factors in the periphery. The time course of innervation of the neck region of the chick has not been bryos between the C2 and neighboring segments at stages 17-18 and 21 when we apply NGF. The distribution of carefully studied, but the slightly more caudal DRG innervating the wings only begins around St. 25. Examination either of these molecules at the segmental level in the chick embryo has not been reported to date. We are now perof sections of embryos stained with HNK or b-tubulin antibodies to reveal axons showed that C5's nerves had just forming in situ hybridizations and immunocytochemistry to investigate this issue. Precedents have been described for reached the myotome and dermis at St. 23 stage (data not shown). Even more strikingly, there was a great deal of cell axial level-specific effects and distributions of neurotrophic factors in development. For example, it was found that modeath in C2 at St. 20, when very few neurons have differentiated in the DRG (McMillan-Carr and Simpson, 1978) , and toneurons in culture from wing levels of the neuraxis were more sensitive to NT-3 and BDNF than those from the level the somite had just begun to differentiate into its component parts. Our observations are of St. 23 embryos that reof the axis innervating the legs. In other experiments, it was observed that DRG cells from limb-innervating levels ceived NGF at St. 17-18 and 20 and are therefore likely to precede the stage when the targets of cervical DRG are of the neuraxis expressed higher levels of trkC (Mettling et al., 1993) . This is likely due to the increased proportion of actually innervated. This would suggest that if NGF is indeed required for survival of some precursors in the early NT-3-responsive muscle -sensory neurons at these levels (Hory-Lee et al., 1993) . DRG, the source of the factor is local. NGF mRNA has been shown to be present in the DRG itself (Zhang et al., 1994 ) Several known characteristics of NGF actions potentially complicate the interpretation of our results. First, it has and those tissues that surround it: the neural tube (Yip and
